Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 14;8(3):e019280.
doi: 10.1136/bmjopen-2017-019280.

Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials

Affiliations

Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials

Irene Bighelli et al. BMJ Open. .

Abstract

Introduction: There is rising awareness that we need multidisciplinary approaches integrating psychological treatments for schizophrenia, but a comprehensive evidence based on their relative efficacy is lacking. We will conduct a network meta-analysis (NMA), integrating direct and indirect comparisons from randomised controlled trials (RCTs) to rank psychological treatments for schizophrenia according to their efficacy, acceptability and tolerability.

Methods and analysis: We will include all RCTs comparing a psychological treatment aimed at positive symptoms of schizophrenia with another psychological intervention or with a no treatment condition (waiting-list and treatment as usual). We will include studies on adult patients with schizophrenia, excluding specific subpopulations (eg, first-episode patients or patients with psychiatric comorbidities). Primary outcome will be the change in positive symptoms on a published rating scale. Secondary outcomes will be acceptability (dropout), change in overall and negative symptoms of schizophrenia, response, relapse, adherence, depression, quality of life, functioning and adverse events. Published and unpublished studies will be sought through database searches, trial registries and websites. Study selection and data extraction will be conducted by at least two independent reviewers. We will conduct random-effects NMA to synthesise all evidences for each outcome and obtain a comprehensive ranking of all treatments. NMA will be conducted in Stata and R within a frequentist framework. The risk of bias in studies will be evaluated using the Cochrane Risk of Bias tool and the credibility of the evidence will be evaluated using an adaptation of the Grading of Recommendations Assessment, Development and Evaluation framework to NMA, recommended by the Cochrane guidance. Subgroup and sensitivity analyses will be conducted to assess the robustness of the findings.

Ethics and dissemination: No ethical issues are foreseen. Results from this study will be published in peer-reviewed journals and presented at relevant conferences.

Prospero registration number: CRD42017067795.

Keywords: adult psychiatry; network meta-analysis; psychological interventions; psychotherapy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: SL in the past 3 years has received honoraria for consulting from Roche, TEVA, Otsuka, Lundbeck and LB Pharma; for lectures from Otsuka, Lundbeck, Janssen, ICON, Lilly, Sanofi Aventis, AOP Orphan, Roche and Servier; and for a publication from Roche. TAF has received lecture fees from Eli Lilly, Janssen, Meiji, Mitsubishi-Tanabe, MSD and Pfizer and consultancy fees from Takeda Science Foundation. He has received royalties from Igaku-Shoin and Nihon Bunka Kagaku-sha publishers. He has received research support from Mochida and Mitsubishi-Tanabe.

Similar articles

Cited by

References

    1. Vos T, Flaxman AD, Naghavi M, et al. . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163–96. 10.1016/S0140-6736(12)61729-2 - DOI - PMC - PubMed
    1. Leucht S, Cipriani A, Spineli L, et al. . Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382:951–62. 10.1016/S0140-6736(13)60733-3 - DOI - PubMed
    1. National Collaborating Centre for Mental Health. Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (Clinical Guideline CG82). London 2009.
    1. Buchanan RW, Kreyenbuhl J, Kelly DL, et al. . The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010;36:71–93. 10.1093/schbul/sbp116 - DOI - PMC - PubMed
    1. Pinquart M, Oslejsek B, Teubert D. Efficacy of systemic therapy on adults with mental disorders: A meta-analysis. Psychother Res 2016;26:241–57. 10.1080/10503307.2014.935830 - DOI - PubMed

Publication types

MeSH terms